These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Diabetes mellitus. XII. Oral diabetes therapy]. Bruns W; Michaelis D; Wappler E Z Arztl Fortbild (Jena); 1971 Feb; 65(3):125-30. PubMed ID: 5575105 [No Abstract] [Full Text] [Related]
7. [HB 419, a new oral antidiabetic; administration to the aged]. Hirn S; Königstein RP Wien Med Wochenschr; 1969 Sep; 119(38):632-3. PubMed ID: 5344309 [No Abstract] [Full Text] [Related]
8. Clinical evaluation of the effect of glyclopyramide in diabetes mellitus. Yamagata S; Goto Y; Oneda A; Kikuchi J; Toyota T Tohoku J Exp Med; 1969 Jun; 98(2):155-69. PubMed ID: 5811101 [No Abstract] [Full Text] [Related]
9. [A new hypoglycemic sulfonamide: AN1324]. Vignalou J; Beck H Presse Med (1893); 1968 Oct; 76(38):1827-8. PubMed ID: 5737547 [No Abstract] [Full Text] [Related]
10. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)]. Vague P; Vague J Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752 [No Abstract] [Full Text] [Related]
11. Acute and chronic studies using a new oral hypoglycemic agent, glyburide. Herrold JN; Tzagournis M; Skillman TG Metabolism; 1971 Apr; 20(4):414-21. PubMed ID: 4927607 [No Abstract] [Full Text] [Related]
12. Clinical and metabolic study in diabetic patients treated with glibenclamide. Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlihson RW; Woodroffe F Br Med J; 1970 Jun; 2(5709):568-70. PubMed ID: 5526611 [TBL] [Abstract][Full Text] [Related]
13. [Effects of ponderal on the state of carbohydrate metabolism and insulin secretion in type 2 diabetes mellitus]. Balabolkin MI; Novikova OM; Levitskaia ZI Sov Med; 1991; (11):56-9. PubMed ID: 1767320 [No Abstract] [Full Text] [Related]
14. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]. Haupt E; Beyer J; Schöffling K Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186 [No Abstract] [Full Text] [Related]
15. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents. Herman JB Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689 [No Abstract] [Full Text] [Related]
16. Effect of prolonged glyclazide treatment on blood glucose and plasma insulin responses in obese patients with maturity-onset diabetes. Wajchenberg BL; Nery M; Leme CE; Silveira AA; Fioratti P; Germek OA Clin Pharmacol Ther; 1980 Mar; 27(3):375-8. PubMed ID: 6987025 [TBL] [Abstract][Full Text] [Related]
17. Improvement in both insulin sensitivity and release following diabetic coma. Alford FP; Martin FI; Pearson MJ Diabetes; 1971 Apr; 20(4):246-9. PubMed ID: 4994562 [No Abstract] [Full Text] [Related]
18. Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect. Hecht A; Gershberg H; Hulse M Metabolism; 1973 May; 22(5):723-33. PubMed ID: 4704717 [No Abstract] [Full Text] [Related]
19. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus]. Mordkovskaia NM Probl Endokrinol (Mosk); 1971; 17(5):121-5. PubMed ID: 4337075 [No Abstract] [Full Text] [Related]
20. [Diabetes equilibration and evolution of weight curves in obese diabetic patients of type 1, during treatment with glucidoral]. Joubaud F Therapeutique; 1971 May; 47(5):465-8. PubMed ID: 5562481 [No Abstract] [Full Text] [Related] [Next] [New Search]